Protez Pharmaceuticals

Develops antibiotics for hospital infections caused by drug-resistant bacteria

placeMalvern, Pennsylvania, United States calendar_todayFounded 2003 groups6 employees language protez.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 13 times.

YearFilings
20121

Investor mix

7 investors on record; lead investors include Birchmere Ventures, BioAdvance.

Investor typeCountShare
Venture capital571%
Angel & family office114%
Other / undisclosed114%
Coming soon